BioSpace News Archive

Cognition Therapeutics, Inc. today announced the pricing of its upsized initial public offering of 3,768,116 shares of its common stock at a public offering price of $12.00 per share.

Motion Acquisition Corp. (“Motion”) (Nasdaq: MOTN), a publicly traded special purpose acquisition company, announced today that its merger partner Ambulnz , Inc., dba DocGo , a leading provider of last-mile Mobile Health services and integrated medical mobility solutions, will present at the 14th annual LD Micro Main Event

M6P Therapeutics to Present at the 17 th Annual International Congress on Neuronal Ceroid Lipofuscinosis

Evofem Biosciences, Inc., (NASDAQ: EVFM) today commented on a letter from leaders in the House of Representatives to senior Biden Administration officials calling for action to ensure coverage for the full range of contraceptives under the Affordable Care Act (ACA).

H3 Biomedicine Inc. today announced it will be providing an update on its intratumoral E7766 clinical program for advanced solid tumors or lymphomas in a poster presentation at the 2021 American Association for Cancer Research

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).

Guardant Health, Inc. today announced it will report financial results for the third quarter 2021 after market close on Thursday, November 4, 2021.

Today, Limbix announced the launch of SparkRx, the first evidence-based digital therapeutic for teens and young adults experiencing symptoms of depression.

TOMI Environmental Solutions, Inc.® today announced that Dr. Halden Shane, Chief Executive Officer, will be presenting at the LD Micro Main Event on Tuesday, October 12, 2021 at 6:30 P.M. ET

Specialty Pharmacy Nursing Network, Inc (SPNN), a national provider of specialty home infusion nursing services is pleased to announce that Cheryl Allen , BS Pharm, MBA has joined the company as EVP Business Development. Before joining SPNN, Cheryl was EVP Business Development and Industry Relations at Asembia and Principal Consu